As per MRFR analysis, the US Cortisone Shots Market Size was estimated at 575.4 (USD Million) in 2023. The US Cortisone Shots Market Industry is expected to grow from 650(USD Million) in 2024 to 1,300 (USD Million) by 2035. The US Cortisone Shots Market CAGR (growth rate) is expected to be around 6.504% during the forecast period (2025 - 2035).
The US Cortisone Shots Market is witnessing significant trends driven by the increasing prevalence of conditions such as arthritis, bursitis, and other inflammatory disorders. The aging population in the United States is a major market driver, as older adults are more likely to suffer from these conditions and seek treatment options. Additionally, the growing awareness of non-surgical treatment options for pain relief is encouraging patients and healthcare providers to consider cortisone shots as a viable alternative. The accessibility and ease of administration of these injections further contribute to their popularity in outpatient settings, making them a preferred choice for many healthcare practitioners.
There are notable opportunities in the US market that can be explored, particularly in terms of advancements in medical technology and improved injection techniques. These advancements can enhance the effectiveness of cortisone shots, leading to higher patient satisfaction and better outcomes. A focus on personalized treatment plans, based on individual patient needs, could also enhance the demand for these injections. Moreover, the rise of telemedicine post-pandemic has opened new avenues for consultations, allowing patients to receive expert advice on cortisone shot therapies more conveniently.
In recent times, there has been an increasing trend towards research and clinical studies examining the long-term efficacy and safety of cortisone injections. This research is crucial in providing clinicians with a clearer understanding of the treatment's benefits versus potential risks. Moreover, there is a growing emphasis on integrating cortisone shots into broader pain management strategies, reflecting a more holistic approach to treating chronic conditions. As the healthcare landscape in the US continues to evolve, these trends indicate a robust outlook for the Cortisone Shots Market in the coming years.
Source: Primary Research, Secondary Research, MRFR Database and Analyst Review
The rising prevalence of chronic diseases, particularly among the aging population in the United States, is significantly driving the growth of the US Cortisone Shots Market Industry. According to the Centers for Disease Control and Prevention, approximately 60% of adults in the US have a chronic disease, while 40% have two or more. Conditions such as arthritis, autoimmune diseases, and orthopedic issues that are treated frequently with cortisone shots have surged, particularly due to the aging Baby Boomer demographic, which is projected to continue to grow as they reach older age brackets.
Major health organizations, including the American Arthritis Foundation, estimate that by 2030, more than 67 million US adults will have doctor-diagnosed arthritis. This significant increase in patients requiring cortisone treatments elevates the demand for cortisone shots, hence driving market growth.
Innovations in injection techniques and the development of advanced corticosteroid medications are poised to enhance the efficacy and safety of cortisone shots, contributing favorably to the US Cortisone Shots Market Industry. The advent of ultrasound-guided injections allows for more precise targeting of the affected areas, reducing patient discomfort and improving outcomes. According to the American Society of Regional Anesthesia and Pain Medicine, the use of ultrasound guidance can increase the success rate of these procedures by over 50%.This increased effectiveness, supported by organizations like the American Medical Association, is likely to boost the adoption of cortisone injections in clinical practices across the US, thereby propelling market growth.
Growing public awareness and acceptance of corticosteroid treatments, notably cortisone shots, are significantly influencing the expansion of the US Cortisone Shots Market Industry. Public health campaigns led by reputable organizations like the National Institutes of Health have highlighted the benefits and effectiveness of corticosteroids in alleviating pain and inflammation associated with various conditions. This advocacy has led to an increase in patients proactively seeking cortisone shots as a treatment option.
According to a national health survey, around 30% of adults have indicated a willingness to consider corticosteroid treatments following educational campaigns about their benefits, which, in turn, is anticipated to drive market growth.
The US Cortisone Shots Market presents a significant opportunity for healthcare providers and patients alike, particularly in the Type segment, which encompasses various injection methods utilized for pain relief and inflammation reduction. Among these, articular or joint injections are pivotal, targeting inflamed joints effectively to enhance mobility and quality of life for patients suffering from conditions like arthritis. This particular method has gained traction due to its direct approach in delivering therapeutic agents precisely where they are needed.
Epidural steroid injections represent another notable aspect of the Type segment, providing relief for patients grappling with back pain and related neurological symptoms due to spinal nerve compression. This method has seen an increase in acceptance as it offers targeted pain management, improving functionality and reducing reliance on systemic medications. Meanwhile, trigger point injections have carved out their own niche by addressing myofascial pain syndromes, which are prevalent in both active individuals and those in sedentary jobs. This technique often results in rapid relief and promotes recovery without the prolonged use of medication.
Each of these injection types has its own unique benefits and applications, making them critical components of the overall US Cortisone Shots Market dynamics.The market also includes other forms of injections that cater to a variety of conditions beyond the commonly used ones, providing a broader spectrum for pain management solutions. As the prevalence of musculoskeletal disorders increases, the importance of the Type segment in the US Cortisone Shots Market is underscored, aligning well with the growing demand for efficient pain management strategies.
Understanding the intricacies of these injection types not only helps healthcare professionals offer personalized treatments but also highlights opportunities for innovation and development within the industry. This dynamic landscape is driven by factors such as ongoing advancements in injection techniques, patient awareness of treatment options, and the increasing burden of chronic pain conditions within the US population, all of which contribute to the robust growth potential of the US Cortisone Shots Market.
Source: Primary Research, Secondary Research, MRFR Database and Analyst Review
The US Cortisone Shots Market is primarily segmented by Indication, which includes various conditions such as rheumatoid arthritis, psoriatic arthritis, bursitis, allergic reactions, skin conditions, and others. Rheumatoid arthritis remains a critical area due to its chronic nature and the need for effective anti-inflammatory treatment, making cortisone shots a preferred option for many patients. Similarly, psoriatic arthritis is notable for its significant impact on patient mobility and quality of life, driving the demand for cortisone interventions.
Bursitis, often resulting from repetitive motions or injuries, highlights the importance of cortisone shots in providing relief for individuals involved in physically demanding occupations. Allergic reactions and skin conditions show the versatility of cortisone shots, as they are used to manage symptoms from a range of diseases, underscoring their relevance in dermatological treatments. The diverse spectrum of indications emphasizes not only the applications of cortisone shots in clinical practice but also presents numerous growth opportunities within the US Cortisone Shots Market, with increasing awareness and research focused on effective treatment options for these conditions.
The US Cortisone Shots Market is significantly influenced by various End User categories, which include hospitals, clinics, sports medicine centers, pharmaceutical companies, and others. Hospitals tend to dominate this market due to their extensive patient bases and ability to provide a wide range of treatments, including advanced procedures. Clinics play a pivotal role as well, as they offer outpatient services that are crucial for administering cortisone shots effectively. Sports medicine centers are also key players, catering to athletes who benefit from these injections for injury recovery and pain management, highlighting the shots' importance in sports-related therapies.
Pharmaceutical companies remain integral, producing and supplying essential medications used in cortisone shots. The overall trends in the US healthcare landscape, such as an increase in chronic diseases and an aging population, are expected to drive the demand for cortisone shots. Additionally, opportunities for growth exist in enhancing treatment protocols and advancing the formulation of injectable steroids, thereby enhancing efficacy and patient outcomes. The diversification across the End User spectrum presents a holistic view of the market dynamics, reflecting the broad applicability of cortisone shots in managing various health conditions.
The US Cortisone Shots Market is characterized by a dynamic and competitive landscape where innovation, regulatory compliance, and pricing strategies play vital roles. The growing prevalence of chronic inflammatory conditions, alongside an aging population, has led to a rising demand for corticosteroid injections. As healthcare providers and patients seek effective pain management solutions, various pharmaceutical companies are striving to leverage their market positions.
The competitive insights within this market reveal not only the strategic initiatives undertaken by key players but also their ability to adapt to changing healthcare policies and consumer needs. This competition is further intensified by the introduction of generic alternatives, which impacts pricing and access for patients. Furthermore, the regulatory environment surrounding the approval and marketing of cortisone shots necessitates that companies remain vigilant and compliant, ensuring the safety and efficacy of their products.
Teva Pharmaceutical Industries stands out in the US Cortisone Shots Market due to its robust product portfolio and strong presence in the prescription medication segment. With a commitment to delivering high-quality and affordable healthcare solutions, Teva leverages its extensive experience in the pharmaceuticals sector to offer a variety of cortisone preparations, catering to different patient needs.
The company’s strategic focus on research and development enables it to enhance its product offerings continually, thereby solidifying its competitive edge. Teva's established relationships with healthcare providers and its adaptive market strategies enable it to maintain significant visibility and accessibility in this niche segment, aiding patients in managing troubling conditions effectively. The company's infrastructure supports large-scale production and distribution, ensuring that medication availability remains consistent.
Merck and Co is another prominent player in the US Cortisone Shots Market, known for its commitment to innovation and patient care. With a well-structured portfolio that includes cortisone-based solutions, Merck emphasizes research-driven development that aligns with critical therapeutic needs. Their products are designed to address inflammatory and autoimmune conditions, which are prevalent in the US. Merck benefits from strong market presence thanks to its reputable brand image and trust among healthcare professionals and patients alike.
The company has pursued various mergers and acquisitions strategically aimed at expanding its capabilities and enhancing its service offerings within the cortisone market. This approach not only strengthens their portfolio but also permits them to leverage cutting-edge technology for product development. Merck remains focused on delivering effective treatments while ensuring compliance with industry regulations, thus reinforcing its competitive position in the dynamic landscape of cortisone shots in the US.
The US Cortisone Shots Market has seen notable developments recently. Companies like Teva Pharmaceutical Industries and Novartis have been refining their cortisone formulations to enhance efficacy and reduce side effects, influenced by the increasing patient demand for more effective pain management solutions. Additionally, AstraZeneca's research has focused on the underlying mechanisms of inflammation, leading to potential advancements in cortisone therapy.
In terms of mergers and acquisitions, Merck and Co announced plans to acquire a smaller biopharmaceutical firm specialized in inflammation which completed in April 2023. This acquisition is expected to bolster Merck's portfolio in the pain management sector.
Furthermore, growth in market valuation is observed, with industry estimates projecting a compound annual growth rate of over 5% through 2025, driven by rising orthopedic and inflammatory disorders in the US.Moreover, the increase in regulatory approvals for new cortisone formulations, such as those from Bristol-Myers Squibb and Regeneron Pharmaceuticals over the past 2-3 years, underlines the competitive nature of the market. Overall, the US Cortisone Shots Market remains dynamic, with continuous advancements and strategic collaborations shaping its future landscape.
| Report Attribute/Metric Source: | Details |
| MARKET SIZE 2018 | 575.4(USD Million) |
| MARKET SIZE 2024 | 650.0(USD Million) |
| MARKET SIZE 2035 | 1300.0(USD Million) |
| COMPOUND ANNUAL GROWTH RATE (CAGR) | 6.504% (2025 - 2035) |
| REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| BASE YEAR | 2024 |
| MARKET FORECAST PERIOD | 2025 - 2035 |
| HISTORICAL DATA | 2019 - 2024 |
| MARKET FORECAST UNITS | USD Million |
| KEY COMPANIES PROFILED | Teva Pharmaceutical Industries, Merck and Co, Novartis, AstraZeneca, Eli Lilly, BristolMyers Squibb, Sandoz, Regeneron Pharmaceuticals, Pfizer, Amgen, AbbVie, Hikma Pharmaceuticals, Sanofi, Johnson and Johnson, Mylan |
| SEGMENTS COVERED | Type, Indication, End User |
| KEY MARKET OPPORTUNITIES | Growing demand for pain management, Increasing prevalence of orthopedic disorders, Rising geriatric population requiring treatment, Expansion of minimally invasive procedures, Advancements in cortisone formulations. |
| KEY MARKET DYNAMICS | Rising prevalence of musculoskeletal disorders, Increasing geriatric population, Advancements in injection techniques, Growing awareness of treatment options, Expanding healthcare access and coverage |
| COUNTRIES COVERED | US |
Frequently Asked Questions (FAQ) :
The US Cortisone Shots Market is expected to be valued at 650.0 million USD by 2024.
By 2035, the market is projected to double in size, reaching an estimated value of 1300.0 million USD.
The market is anticipated to grow at a compound annual growth rate of 6.504 percent during the period from 2025 to 2035.
Articular or joint injections are expected to dominate the market with a value of 260.0 million USD in 2024.
The market for epidural steroid injections is projected to reach 360.0 million USD by 2035.
Key players include Teva Pharmaceutical Industries, Merck and Co, Novartis, AstraZeneca, and Eli Lilly, among others.
The market for trigger point injections is expected to grow to 200.0 million USD by 2035.
Emerging trends are driving growth by improving treatment options and increasing the market size significantly.
There are opportunities in expanding treatment applications and increasing patient awareness contributing to market growth.
The 'others' segment is valued at 110.0 million USD in the year 2024.
Leading companies partner with us for data-driven Insights.
Kindly complete the form below to receive a free sample of this Report
Analyst Explore the profile of garvit vyas, one of our esteemed authors at market research future, and access their expert research contributions in the field of market research and industry analysis
Get in Touch
© 2025 Market Research Future ® (Part of WantStats Reasearch And Media Pvt. Ltd.)
